REFERENCES
1 . Francis A . Catatonia : diagnosis , classification , and treatment . Curr Psychiatry Rep . 2010 ; 12 ( 3 ): 180-185 . doi : 10.1007 / S11920-010-0113-Y .
2 . Filley CM , McConnell B V ., Anderson CA . The Expanding Prominence of Toxic Leukoencephalopathy . https :// doi . org / 101176 / appi . neuropsych17010006 . 2017 ; 29 ( 4 ): 308-318 . doi : 10.1176 / APPI . NEUROPSYCH . 17010006 .
3 . Maschke M , Fehlings T , Kastrup O , Wilhelm HW , Leonhardt G . Toxic leukoencephalopathy after intravenous consumption of heroin and cocaine with unexpected clinical recovery . J Neurol . 1999 ; 246 ( 9 ): 850- 851 . doi : 10.1007 / S004150050469 .
4 . Tormoehlen LM . Toxic leukoencephalopathies . Neurol Clin . 2011 ; 29 ( 3 ): 591-605 . doi : 10.1016 / J . NCL . 2011.05.005 .
5 . Holyoak AL , Trout MJ , White RP , Prematuranga S , Senthuran S . Toxic leukoencephalopathy in the intensive care unit . Anaesth Intensive Care . 2014 ; 42 ( 6 ): 782-788 . doi : 10.1177 / 0310057x1404200615 .
6 . B B , F M , L T , K C , F B , P L . Acute leukoencephalopathy after buprenorphine intoxication in a 2-year-old child . Eur J Paediatr Neurol . 2011 ; 15 ( 4 ): 368-371 . doi : 10.1016 / J . EJPN . 2011.03.002 .
7 . Cheng MY , Chin SC , Chang YC , et al . Different routes of heroin intake cause various heroin-induced leukoencephalopathies . J Neurol . 2019 ; 266 ( 2 ): 316-329 . doi : 10.1007 / S00415-018-9131-1 .
8 . Walther S , Stegmayer K , Wilson JE , Heckers S . Structure and neural mechanisms of catatonia . The Lancet Psychiatry . 2019 ; 6 ( 7 ): 610-619 . doi : 10.1016 / S2215-0366 ( 18 ) 30474-7 .
9 . Anbarasan D , Campion P , Howard J . Drug-induced leukoencephalopathy presenting as catatonia . Gen
Hosp Psychiatry . 2011 ; 33 ( 1 ): 85 . e1-85 . e3 . doi : 10.1016 / J . GENHOSPPSYCH . 2010.11.006 .
10 . Seet RCS , Rathakrishnan R , Chan BP , Lim ECH . Diffuse cystic leucoencephalopathy after buprenorphine injection . J Neurol Neurosurg Psychiatry . 2005 ; 76 ( 6 ): 890 . doi : 10.1136 / JNNP . 2004.052878 .
11 . Filley CM , Kleinschmidt-DeMasters BK . Toxic Leukoencephalopathy . N Engl J Med . 2001 ; 345 ( 6 ): 425-432 . doi : 10.1056 / nejm200108093450606 .
12 . Al-Chalabi M , Lateef S , Gharaibeh K , Saraiya P , Ghannam M . Mimicking a Psychiatric Disorder : Heroin- Induced Leukoencephalopathy . Cureus . 2020 ; 12 ( 10 ). doi : 10.7759 / CUREUS . 10805 .
13 . S G , A M , A F , J DK . Delayed akinetic catatonic mutism following methadone overdose . Neurotoxicology . 2010 ; 31 ( 6 ): 762-764 . doi : 10.1016 / J . NEURO . 2010.07.007 .
14 . Jeyaventhan R , Thanikasalam R , Mehta MA , et al . Clinical Neuroimaging Findings in Catatonia : Neuroradiological Reports of MRI Scans of Psychiatric Inpatients With and Without Catatonia . https :// doi . org / 101176 / appi . neuropsych21070181 . Published online April 13 , 2022 . doi : 10.1176 / APPI . NEUROPSYCH . 21070181 .
15 . First MB . DSM-5 ® Handbook of Differential Diagnosis . DSM-5 ® Handb Differ Diagnosis . Published online November 19 , 2013 . doi : 10.1176 / APPI . BOOKS . 9781585629992 .
16 . LT K , JM C , MS D . To Err Is Human . National Academies Press ; 2000 . doi : 10.17226 / 9728 .
17 . Funayama M , Takata T , Koreki A , Ogino S , Mimura M . Catatonic Stupor in Schizophrenic Disorders and Subsequent Medical Complications and Mortality . Psychosom Med . 2018 ; 80 ( 4 ): 370-376 . doi : 10.1097 / PSY . 0000000000000574 .
18 . Fink M , Taylor MA . The many varieties of catatonia . Eur Arch Psychiatry Clin Neurosci . 2001 ; 251 ( SUPPL . 1 ): 8-13 . doi : 10.1007 / pl00014200 .
19 . Bush G , Fink M , Petrides G , Dowling F , Francis A . Catatonia . I . Rating scale and standardized examination . Acta Psychiatr Scand . 1996 ; 93 ( 2 ): 129- 136 . doi : 10.1111 / J . 1600-0447.1996 . TB09814 . X .
20 . Rasmussen SA , Mazurek MF , Rosebush PI . Catatonia : Our current understanding of its diagnosis , treatment and pathophysiology . Published online 2016 . doi : 10.5498 / wjp . v6 . i4.391 .
21 . Tibrewal P , Narayanaswamy J , Zutshi A , Srinivasaraju R , Math SB . Response rate of lorazepam in catatonia : A developing country ’ s perspective . Prog Neuro-Psychopharmacology Biol Psychiatry . 2010 ; 34 ( 8 ): 1520-1522 . doi : 10.1016 / j . pnpbp . 2010.08.017 .
22 . Suchandra HH , Reddi VSK , Aandi Subramaniyam B , Muliyala KP . Revisiting lorazepam challenge test : Clinical response with dose variations and utility for catatonia in a psychiatric emergency setting . Aust N Z J Psychiatry . 2021 ; 55 ( 10 ): 993-1004 . doi : 10.1177 / 0004867420968915 .
23 . Narayanaswamy JC , Tibrewal P , Zutshi A , Srinivasaraju R , Math SB . Clinical predictors of response to treatment in catatonia . Gen Hosp Psychiatry . 2012 ; 34 ( 3 ): 312-316 . doi : 10.1016 / J . GENHOSPPSYCH . 2012.01.011 .
24 . Unal A , Altindag A , Demir B , Aksoy I . The Use of Lorazepam and Electroconvulsive Therapy in the Treatment of Catatonia : Treatment Characteristics and Outcomes in 60 Patients . J ECT . 2017 ; 33 ( 4 ): 290-293 . doi : 10.1097 / YCT . 0000000000000433 .
25 . Pelzer AC , van der Heijden FM , den Boer E . Systematic review of catatonia treatment . Neuropsychiatr Dis Treat . 2018 ; 14:317-326 . doi : 10.2147 / NDT . S147897 .
West Virginia Medical Journal • December 2022 • 29